Conference Coverage
Conference Coverage
SGLT2 inhibitor use tied to fewer atrial arrhythmias
Conference Coverage
Could an oral PCSK9 inhibitor be on the horizon?
What if the cholesterol-crushing efficacy of current PCSK9 inhibitors came in a pill instead of a syringe? That’s one possibility for a Merck...
Conference Coverage
Empagliflozin a winner in challenging arena of stabilized acute HF
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of...
Conference Coverage
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
Conference Coverage
ASCEND: Aspirin shows hint of dementia protection in T2D
Conference Coverage
In diabetes, fast-growing pancreatic cysts may be a red flag
Faster growth rates of pancreatic cysts in the presence of diabetes are important because they represents a potential mark for cyst aggressiveness...
Conference Coverage
Finerenone, sotagliflozin exert heart failure benefits despite renal dysfunction
Secondary trial analyses in patients with type 2 diabetes showed both finerenone and sotagliflozin had heart failure benefits across the spectrum...
Conference Coverage
More STEP data: Semaglutide cuts weight, cravings, beats liraglutide
In STEP 5, weight loss with semaglutide was sustained at 2 years and the drug cut cravings in a subgroup; in STEP 8, semaglutide beat liraglutide...
Conference Coverage
AHA 2021 puts scientific dialogue, health equity center stage
The Scientific Sessions are fully online but with a heavy emphasis on live events and opportunities to interact globally over the latest...
Conference Coverage
Liraglutide effective against weight regain after gastric bypass
In a randomized controlled trial of patients who regained weight after a gastric bypass, 69% of patients given liraglutide lost at least 5% of...